Health Catalyst Announces CEO Dan Burton to Step Down to Pursue Service Opportunities
Health Catalyst (NASDAQ: HCAT) announced that CEO Dan Burton will step down from his position effective June 30, 2026, to pursue volunteer service opportunities with his wife in support of their faith. Burton, who has led the company for 15 years, will continue to serve on the Board and support the search for a new CEO.
Under Burton's leadership, Health Catalyst grew from a 3-person team to a public company with 1,100 healthcare clients and 1,400 team members. The company achieved over $2.2 billion in client-approved improvements and maintained exceptional team member engagement levels between the 94th and 99th percentile over the past decade, earning more than 125 Best Workplace Awards since 2013.
Health Catalyst (NASDAQ: HCAT) ha annunciato che il CEO Dan Burton lascer脿 il suo incarico a partire dal 30 giugno 2026 per dedicarsi ad attivit脿 di volontariato insieme a sua moglie, in linea con la loro fede. Burton, che ha guidato l'azienda per 15 anni, continuer脿 a far parte del Consiglio di Amministrazione e a supportare la ricerca del nuovo CEO.
Sotto la guida di Burton, Health Catalyst 猫 cresciuta da un team di 3 persone a una societ脿 quotata in borsa con 1.100 clienti nel settore sanitario e 1.400 collaboratori. L'azienda ha raggiunto oltre 2,2 miliardi di dollari in miglioramenti approvati dai clienti e ha mantenuto livelli di coinvolgimento dei collaboratori eccezionali, tra il 94掳 e il 99掳 percentile nell'ultimo decennio, ottenendo pi霉 di 125 premi come Miglior Luogo di Lavoro dal 2013.
Health Catalyst (NASDAQ: HCAT) anunci贸 que su CEO, Dan Burton, dejar谩 su cargo a partir del 30 de junio de 2026 para dedicarse a actividades de voluntariado junto a su esposa en apoyo a su fe. Burton, quien ha liderado la empresa durante 15 a帽os, seguir谩 formando parte del Consejo y apoyando la b煤squeda de un nuevo CEO.
Bajo el liderazgo de Burton, Health Catalyst creci贸 de un equipo de 3 personas a una empresa p煤blica con 1,100 clientes en el sector salud y 1,400 empleados. La compa帽铆a logr贸 m谩s de $2.2 mil millones en mejoras aprobadas por los clientes y mantuvo niveles excepcionales de compromiso entre sus empleados, ubic谩ndose entre el percentil 94 y 99 durante la 煤ltima d茅cada, ganando m谩s de 125 premios al Mejor Lugar para Trabajar desde 2013.
Health Catalyst (NASDAQ: HCAT)電� CEO Dan Burton鞚� 2026雲� 6鞗� 30鞚�攵�搿� 鞛愲Μ鞐愳劀 氍茧煬雮� 鞁犾暀鞚� 氚旐儠鞙茧 鞎勲偞鞕� 頃粯 鞛愳洂氪夓偓 頇滊彊鞐� 鞝勲厫頃� 瓴冹澊霛缄碃 氚滍憸頄堨姷雼堧嫟. 15雲勱皠 須岇偓毳� 鞚措亴鞏挫槰 Burton鞚� 鞚挫偓須岇棎 瓿勳啀 彀胳棳頃橂┌ 靸堧鞖� CEO 靹犾瀯鞚� 歆�鞗愴暊 鞓堨爼鞛呺媹雼�.
Burton鞚� 毽崝鞁� 鞎勲灅 Health Catalyst電� 3氇呾潣 韺�鞐愳劀 鞁滌瀾頃� 1,100臧滌潣 鞚橂 瓿犼皾瓿� 1,400氇呾潣 歆侅洂鞚� 氤挫湢頃� 靸侅灔 旮办梾鞙茧 靹膘灔頄堨姷雼堧嫟. 須岇偓電� 瓿犼皾 鞀轨澑 臧滌劆鞎§澊 22鞏� 雼煬毳� 雱橃棃鞙茧┌, 歆�雮� 10雲勱皠 歆侅洂 彀胳棳霃勱皜 94~99 氚彪秳鞙� 靷澊搿� 毵れ毎 鞖办垬頃� 2013雲� 鞚错泟 125臧� 鞚挫儊鞚� 斓滉碃鞚� 歆侅灔 靸侅潉 靾橃儊頄堨姷雼堧嫟.
Health Catalyst (NASDAQ : HCAT) a annonc茅 que son PDG, Dan Burton, quittera ses fonctions 脿 compter du 30 juin 2026 pour se consacrer 脿 des activit茅s de b茅n茅volat avec son 茅pouse, en lien avec leur foi. Burton, qui a dirig茅 l鈥檈ntreprise pendant 15 ans, continuera 脿 si茅ger au conseil d鈥檃dministration et 脿 soutenir la recherche d鈥檜n nouveau PDG.
Sous la direction de Burton, Health Catalyst est pass茅e d鈥檜ne 茅quipe de 3 personnes 脿 une soci茅t茅 cot茅e en bourse comptant 1 100 clients dans le secteur de la sant茅 et 1 400 collaborateurs. L鈥檈ntreprise a r茅alis茅 plus de 2,2 milliards de dollars d鈥檃m茅liorations valid茅es par ses clients et a maintenu des niveaux d鈥檈ngagement des collaborateurs exceptionnels, situ茅s entre le 94e et le 99e percentile au cours de la derni猫re d茅cennie, remportant plus de 125 prix du meilleur lieu de travail depuis 2013.
Health Catalyst (NASDAQ: HCAT) gab bekannt, dass CEO Dan Burton zum 30. Juni 2026 von seinem Posten zur眉cktreten wird, um gemeinsam mit seiner Frau freiwillige Dienste im Einklang mit ihrem Glauben wahrzunehmen. Burton, der das Unternehmen 15 Jahre lang gef眉hrt hat, wird weiterhin im Vorstand bleiben und die Suche nach einem neuen CEO unterst眉tzen.
Unter Burtons F眉hrung wuchs Health Catalyst von einem 3-k枚pfigen Team zu einem b枚rsennotierten Unternehmen mit 1.100 Kunden im Gesundheitswesen und 1.400 Mitarbeitern. Das Unternehmen erzielte 眉ber 2,2 Milliarden US-Dollar an von Kunden genehmigten Verbesserungen und hielt 眉ber das letzte Jahrzehnt hinweg au脽ergew枚hnlich hohe Mitarbeiterengagement-Werte zwischen dem 94. und 99. Perzentil, was seit 2013 zu mehr als 125 Auszeichnungen als bester Arbeitsplatz f眉hrte.
- Strong leadership legacy with company growth from 3 to 1,400 team members
- Achieved $2.2 billion in client-approved, measurable improvements
- Exceptional team engagement levels (94th-99th percentile)
- Planned, orderly transition with 10-month notice period
- CEO will remain on Board to ensure continuity
- Loss of long-term CEO who led company through IPO and growth phase
- Third senior leadership departure for faith-based service, indicating potential pattern
Insights
Health Catalyst CEO Dan Burton's planned departure in 2026 represents an orderly, well-telegraphed leadership transition after 15 years of successful company growth.
Health Catalyst has announced a significant but orderly leadership transition with CEO Dan Burton stepping down effective June 30, 2026 - providing nearly two years for succession planning. This extended runway is notable in corporate transitions, allowing ample time for a thorough executive search and knowledge transfer process.
Burton's 15-year tenure has been transformative, growing the company from just 3 team members to over 1,400, with 1,100 healthcare clients and documented improvements worth
Several aspects of this announcement stand out from a governance perspective:
- Burton will remain on the Board, providing continuity and institutional knowledge
- The company has experience with similar faith-based departures from senior leadership
- The transition's lengthy timeline suggests confidence in current operations
- The company culture appears strong, with engagement levels between the
94th and99th percentile
For investors, this represents a predictable transition rather than an abrupt departure. The nearly two-year notice period reduces uncertainty and allows for a measured approach to leadership succession. The Board's Nominating and Corporate Governance Committee will lead the CEO search, suggesting adherence to proper governance protocols during this transition.
Mr. Burton to Retire June 30, 2026, Actively Committed to Support Board in Transition and New CEO Search
As a result, Mr. Burton will transition from his full-time position as CEO, effective June 30, 2026, and retire from his full-time work at Health Catalyst. Mr. Burton will support the Board in its search for a new CEO and will continue to serve on the Board.聽
By then, Mr. Burton will have been leading Health Catalyst full-time for 15 years, having joined at an early stage as both an investor and an advisor, when the company consisted of just three team members, in January 2011. He initially planned to serve as interim CEO for only a period of several months. His subsequent, longstanding tenure, as requested by the Board, led to the company's meaningful expansion, including filing for an initial public offering in 2019, growing to include 1,100 active healthcare clients and over 1,400 team members, publishing over 375 documented client case studies of data-driven healthcare improvement, and enabling more than
Mr. Burton's leadership is centered on serving others and a strong commitment to the company's mission. This resulted in Health Catalyst maintaining exceptionally high team member engagement levels, which have consistently ranked between the 94th and 99th percentile during the past decade, according to Gallup assessments. As a result of this focus on team member engagement, Health Catalyst has earned more than 125 Best Workplace Awards since 2013. The company has been recognized by esteemed organizations locally in
It is this servant leadership mindset that also informs Mr. Burton's desire to become more deeply involved with his faith. For many years, Mr. Burton and his wife, Sarah, have planned to pursue mission-oriented service opportunities that align with their faith, after Dan completed his tenure as CEO and their children became adults.
"It has been the highlight of my career to serve in this role, in a company filled with teammates I love, in service of a mission that I believe in, in support of clients who are so deeply committed to that same mission, and with the backing of our shareholders, past and present, who have enabled us to pursue this mission to make healthcare measurably better," Mr. Burton said. "During this transition, I remain deeply committed to strong execution, every day, in support of accomplishing our company's goals and objectives, including driving client and shareholder value."
Jack Kane, Chairman of the Health Catalyst Board of Directors, said, "We, as a Board, would like to thank Dan for his many years of outstanding service to the company in the role of CEO. We are grateful Dan will continue to serve on the Board. Our Nominating and Corporate Governance Committee will conduct a CEO search to identify an effective, world-class CEO to lead Health Catalyst in its next chapter."
This is the third time a member of Health Catalyst's Senior Leadership Team has stepped down from Health Catalyst to provide additional faith-based volunteer service for the Church of Jesus Christ of Latter-Day Saints. In 2023, Health Catalyst's Chief Operating Officer, Paul Horstmeier, was called to serve for three years as the Mission President of the Puerto Rico San Juan Mission. From 2017 to 2020, Health Catalyst Co-Founder Steve Barlow was called to serve as a Mission President in
Health Catalyst, as a mission-driven organization, is grateful for and supportive of the many contributions its team members make in providing various types of volunteer service to the broader community.
About Health Catalyst
Health Catalyst (Nasdaq: HCAT) is a leading provider of data and analytics technology and services that ignite smarter healthcare, lighting the path to measurable clinical, financial, and operational improvement. More than 1,000 organizations worldwide rely on Health Catalyst's offerings, including our cloud-based technology ecosystem, Health Catalyst Ignite鈩�, AI-enabled data and analytics solutions, and expert services to drive meaningful outcomes across hundreds of millions of patient records. Powered by high-value data, standardized measures and registries, and deep healthcare domain expertise, Ignite helps organizations transform complex information into actionable insights. Backed by a multi-decade mission and a proven track record of delivering billions of dollars in measurable results, Health Catalyst continues to serve as the catalyst for massive, data-informed healthcare improvement and innovation.
Media Contact:
Kathryn Mykleseth
PR and Communications Director
[email protected]
Investor Relations Contact:
Jack Knight
Vice President, Investor Relations
+1 (855) 309-6800
[email protected]
View original content to download multimedia:
SOURCE Health Catalyst
FAQ
When is Health Catalyst CEO Dan Burton stepping down?
Why is Dan Burton leaving his position as HCAT CEO?
What are Dan Burton's achievements as Health Catalyst CEO?
Will Dan Burton remain involved with Health Catalyst after stepping down?
How has Health Catalyst performed under Dan Burton's leadership?
